1.Petrin, D, et al. Clinical and microbiological aspects of Trichomonas vaginalis. Clinical Microbiology Reviews 1998; 11: 300–317.
2.World Health Organization (WHO) Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections 2008. Geneva: WHO, 2012.
3.Swygard, H, et al. Trichomoniasis: clinical manifestations, diagnosis and management. Sexually Transmitted Infections 2004; 80: 91–95.
4.Krieger, JN. Consider diagnosis and treatment of trichomoniasis in men. Sexually Transmitted Diseases 2000; 27: 241–242.
5.Wolner-Hanssen, P, et al. Clinical manifestations of vaginal trichomoniasis. Journal of the American Medical Association 1989; 261: 571–576.
6.Schwebke, JR, Burgess, D. Trichomoniasis. Clinical Microbiology Reviews 2004; 17: 794–803.
7.Lewis, DA. Trichomoniasis. Medicine 2010; 38: 291–293.
8.Van der Pol, B. Trichomonas vaginalis infection: the most prevalent nonviral sexually transmitted infection receives the least public health attention. Clinical Infectious Diseases 2007; 44: 23–25.
9.Moodley, P, et al. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clinical Infectious Diseases 2002; 34: 519–522.
10.Cotch, MF, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sexually Transmitted Diseases 1997; 24: 353–360.
11.McClelland, RS, et al. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. Journal of Infectious Diseases 2007; 195: 698–702.
12.Laga, M, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344: 246–248.
13.Sorvillo, F, Kerndt, P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 1998; 351: 213–214.
14.Moodley, P, Connolly, C, Sturm, AW. Interrelationships among human immunodeficiency virus type 1 infection, bacterial vaginosis, trichomoniasis, and the presence of yeasts. Journal of Infectious Diseases 2002; 185: 69–73.
15.Sherrard, J. United Kingdom National Guideline on the Management of Trichomonas vaginalis. London: British Association for Sexual Health and HIV, 2007.
16.Roth, AM, et al. Changing sexually transmitted infection screening protocol will result in improved case finding for Trichomonas vaginalis among high-risk female populations. Sexually Transmitted Diseases 2011; 38: 398–400.
17.Savage, EJ, et al. Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Eurosurveillance 2012; 17.
18.Hughes, G, Simms, I, Leong, G. Data from UK genitourinary medicine clinics, 2006: a mixed picture. Sexually Transmitted Infections 2007; 83: 433–435.
19.McLennan, D, et al. The English Indices of Deprivation 2010. London: Communities and Local Government, 2011.
20.Kelley, CF, et al. Prevalence of urethral Trichomonas vaginalis in black and white men who have sex with men. Sexually Transmitted Diseases 2012; 39: 739.
21.Miller, WC, et al. The prevalence of trichomoniasis in young adults in the United States. Sexually Transmitted Diseases 2005; 32: 593–598.
22.Joyner, JL, et al. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sexually Transmitted Diseases 2000; 27: 236–240.
23.Johnston, VJ, Mabey, DC. Global epidemiology and control of Trichomonas vaginalis. Current Opinion in Infectious Diseases 2008; 21: 56–64.
24.Bachmann, LH, et al. Trichomonas vaginalis genital infections: progress and challenges. Clinical Infectious Diseases 2011; 53 (Suppl. 3): 160–172.
25.Lara-Torre, E, Pinkerton, JS. Accuracy of detection of Trichomonas vaginalis organisms on a liquid-based papanicolaou smear. American Journal of Obstetrics & Gynecology 2003; 188: 354–356.
26.Helms, DJ, et al. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sexually Transmitted Diseases 2008; 35: 484–488.
27.Hughes, G, et al. Comparison of risk factors for four sexually transmitted infections: results from a study of attenders at three genitourinary medicine clinics in England. Sexually Transmitted Infections 2000; 76: 262–267.
28.Sorvillo, F, et al. Trichomonas vaginalis, HIV, and African-Americans. Emerging Infectious Diseases 2001; 7: 927–932.
29.Choudhury, B, et al. Identification of individuals with gonorrhoea within sexual networks: a population-based study. Lancet 2006; 368: 139–146.
30.Krashin, JW, et al. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population. Sexually Transmitted Diseases 2010; 37: 440–444.
31.Mavedzenge, SN, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sexually Transmitted Diseases 2010; 37: 460–466.
32.Van der Pol, B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. Journal of Infectious Diseases 2008; 197: 548–554.
33.Woodland, H, Rogstad, KE. Trichomonas vaginalis in a Sheffield genitourinary medicine department. International Journal of STD & AIDS 2005; 16: 491–493.
34.Mahto, M, et al. Finding cases of Trichomonas vaginalis infection in England. International Journal of STD & AIDS 2011; 22: 471–473.
35.Schwebke, JR, et al. Molecular testing for Trichomonas vaginalis in women: results from a prospective U.S. clinical trial. Journal of Clinical Microbiology 2011; 49: 4106–4111.
36.Ng, A, Ross, J. Nuclei acid amplification tests (NAAT) for Trichomonas vaginalis: should they change who we screen for infection [Abstract]. Sexually Transmitted Infections 2012; 88 (Suppl. 1): A29.
37.Lawton, M, Schembri, G, Kingston, M. Testing for Trichomonas vaginalis (TV) by transcription mediated amplification (TMA). An evaluation in a large city clinic [Abstract]. Sexually Transmitted Infections 2013; 88 (Suppl. 1): A32.
38.Watts, A, et al. Clinical evaluation of diagnostic methods for the detection of Trichomonas vaginalis from high vaginal specimens [Abstract]. International Journal of STD & AIDS 2013; 24 (Suppl. 1): 19.
39.Boyle, S. United Kingdom (England): health system review. Health Systems in Transition 2011; 13: 1–483.
40.British Association for Sexual Health and HIV & The Medical Foundation for AIDS and Sexual Health. Standards for the management of sexually transmitted infections (STIs). London: British Association for Sexual Health and HIV & The Medical Foundation for AIDS and Sexual Health; 2010.
41.McClean, H, et al. BASHH statement on partner notification for sexually transmissible infections. London: British Association for Sexual Health and HIV, 2012.
42.Hobbs, MM, Sena, AC. Modern diagnosis of Trichomonas vaginalis infection. Sexually Transmitted Infections 2013; 89: 434–438.